UFLEX NSE filing

UFLEX Limited Submits Revised Earnings Presentation for Q2 FY27 Conference Call

The RealCase readHigh impact Positive

UFLEX Limited released its revised Q2 FY27 earnings presentation. Consolidated revenue rose 26.1% YoY to ₹48,694 million. Normalized EBITDA increased 94.8% YoY to ₹7,588 million, with margins expanding 550 bps to 15.6%. Net profit grew 682.8% YoY to ₹2,106 million. Capex for H1 FY27 was ₹10,471 million.

Why it matters

The significant increase in financial metrics like revenue, EBITDA, and net profit, along with details on future growth drivers and capex, suggests a high impact on investor sentiment and the company's outlook.

The market read

The company reported strong year-on-year growth in revenue, EBITDA, and net profit, indicating a positive financial performance.

UFLEX Limited has submitted a revised Earnings Presentation in connection with the Earnings Conference Call for the financial results of Q2 and H1 FY27. This revised presentation supersedes the version previously submitted on November 16, 2026. The presentation was shared with the National Stock Exchange of India and the BSE Ltd. on November 16, 2026.

The company reported a strong performance for Q2 FY27 despite geopolitical headwinds and volatile raw material prices. Consolidated revenue grew by 26.1% year-on-year (YoY) to ₹48,694 million, with normalized EBITDA increasing by 94.8% YoY to ₹7,588 million, resulting in a margin expansion of 550 basis points to 15.6%. For H1 FY27, revenue grew 31.9% YoY to ₹102,666 million, and normalized EBITDA increased by 85.7% to ₹15,961 million, with margins expanding by 450 basis points to 15.5%.

Net profit saw a significant YoY growth of 682.8% in Q2 FY27 to ₹2,106 million, and 646.5% in H1 FY27 to ₹6,340 million. The company incurred a total capex of ₹5,689 million in Q2 FY27, contributing to a cumulative capex of ₹10,471 million in H1 FY27. Future growth is expected to be supported by the ramp-up of recently commissioned facilities, including a recycling plant in Noida and a WPP bags facility in Mexico, along with an upcoming aseptic packaging facility in Egypt. The company remains focused on driving sustainable growth and creating long-term value.

Filing to action

What to do with a filing like this

UFLEX Limited filed this with the NSE as a statutory disclosure, categorised under other investor communications. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by UFLEX Limited. Read the original for the full detail.

View original filing